Evidence map›Paper›PMID 41000646›Full record

ArticlebioRxiv : the preprint server for biology2025

Acute kidney injury disrupts cardiac remodeling via SerpinA3N.

Gowda S Pramod, Stanely Qu, Runze Ni, Nadezhda Zeleznova, Minghua Li, Nohely Hernandez, Lei Wang, Nathan Hall, Bi Zhao, Justin Gibbons and 6 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Gowda S PramodDepartment of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida (USF), Tampa, Florida, USA.
Stanely QuDepartment of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida (USF), Tampa, Florida, USA.
Runze NiDepartment of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida (USF), Tampa, Florida, USA.
Nadezhda ZeleznovaDepartment of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida (USF), Tampa, Florida, USA.
Minghua LiDepartment of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida (USF), Tampa, Florida, USA.
Nohely HernandezDepartment of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida (USF), Tampa, Florida, USA.
Lei WangDepartment of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida (USF), Tampa, Florida, USA.
Nathan HallDepartment of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida (USF), Tampa, Florida, USA.
Bi ZhaoDepartment of GenGHS, Genomics Program, College of Public Health, USF, Tampa, Florida, USA.
Justin GibbonsDepartment of GenGHS, Genomics Program, College of Public Health, USF, Tampa, Florida, USA.
N Sanjib BanerjeeDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Ganesh V HaladeDivision of Cardiovascular Sciences, Department of Medicine, Heart Institute, USF, 560 Channelside Dr, Tampa, FL 33602, USA.ORCID 0000-0002-5351-9354
Lucian LozonschiDivision of Cardiothoracic and Transplantation Surgery Tampa General Hospital (TGH), 1 Tampa General Circle, Tampa, FL 33606, USA.ORCID 0000-0003-2205-3229
Enyin LaiUSF-TGH Transplant Research Center (UTRC), USF Health, USF, Tampa, Florida, USA.
Kristof WilliamsDepartment of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida (USF), Tampa, Florida, USA.
Ruisheng LiuDepartment of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida (USF), Tampa, Florida, USA.

Funding

Tubuloglomerular feedback response in AKI to CKD transitionR01DK134028 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI LIU, RUISHENG · 2022 to 2025
$2.6M
Protection of donor kidney and transplanted graft function by modulating Na/K ATPase activityR01DK138092 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI WEI CHEN, RUISHENG LIU · 2024 to 2026
$2.0M
Treatment of lupus nephritis with nanoparticles that selectively target kidney glomeruliR01DK134000 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI RUISHENG LIU, Shyam S Mohapatra · 2023 to 2026
$1.9M
NIDDK NIH HHS R01 DK134000NIDDK NIH HHS R01 DK134028NIDDK NIH HHS R01 DK138092
6 · The paper itself

Abstract

Cardiorenal syndrome type 3 (CRS-3) also known as acute reno-cardiac syndrome, refers to a condition where acute kidney injury (AKI) leads to acute cardiac dysfunction or injury. The underlying mechanisms have not been elucidated. In the current study, we examined the potential mechanisms for the development of myocardial pro-fibrotic factors and cardiac remodeling in C57BL/6J mice after AKI. The mice were subjected to bilateral pedicle clamping for 30 min followed by 24 h of reperfusion. Heart tissue was collected from control (Ctrl) and AKI mice and subjected to proteomic analysis by liquid chromatography-mass spectrometry (LC-MS) and differential mRNA expression analysis by RNA-seq. Cardiac tissue was collected to assess serine protease activity, RNA, protein and cytokine expression. The results indicate that AKI significantly upregulated SerpinA3N in the heart which was negatively correlated with serine protease (Granzyme B) activity. Further, AKI induced the development of several pro-fibrotic factors, induced mitochondrial dysfunction and increased inflammation. Finally, using H9C2 cells we demonstrated that inhibiting SerpinA3N with XAV939 increased Granzyme B activity. Thus, this study suggests that AKI leads to the development of pro-fibrotic factors in the heart and disrupts cardiac remodeling by SerpinA3N mediated inhibition of serine protease Granzyme B activity. Decreased SerpinA3N expression in the heart followed by AKI could lead to a more balanced extracellular matrix (ECM) composition in the heart with an alleviated pro-fibrotic response.

Identifiers

PMID41000646
PMCPMC12458144

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.